📌 Key Takeaways
- Topic: Matting Agent Supplier: How to Choose the Right Silica Matting Agent Partner
- Keywords: fumed silica CAS 112945-52-5
- Published: 2026-11-20 06:09:19
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Submicron Spherical Silica: Specifications and Uses in Underfill and Advanced Packaging
- Fused Silica Powder Supplier: Purity, Particle Size Options and Selection Tips
- Quartz Sand Supplier Egypt: Quality, Grades and Export Options
- Liu, M., Tu, J., Feng, Y., Zhang, J. & Wu, J. Synergistic co-delivery of diacid metabolite of norcantharidin and ABT-737 based on folate-modified lipid bilayer-coated mesoporous silica nanoparticle against hepatic carcinoma. J. Nanobiotechnol. 18, 114 (2020). Post CAS Google Scholar
- Solvay Zeosil: Highly Dispersible Silica Grades for Tires and Rubber
- Silica for Skincare: Benefits for Oil Control, Texture and Soft-Focus Effects
Silica Antiblocking Agent: How It Works, Particle Size Selection and Uses
What is silica (SiO₂)?
silica supplier Indonesia The pH in normal tissues under physiological conditions is typically neutral, while in solid tumors, the tumor microenvironment is normally slightly acidic due to the exuberant metabolism of tumor cells that results in the production of sizable amounts of lactic acid. 337, 338 Therefore, the construction of pH-responsive MSNs nanocarriers can attain targeted drug release and tumor therapy. Wagner et al. functionalized the external surface of MSNs by carboxylic groups, followed by attaching a stimuli-responsive capping system, that consists of a pH-responsive acetal linker and a biotin-avidin gatekeeper. 339 After uptaken by lysosome in tumor environment, the biotin-avidin caps were separated out and the immune-stimulant R848 (resiquimod) could be released, thus achieving improved targeted delivery of immune modulator to antigen-presenting cells. 339 Besides, in the construction of a light-responsive drug delivery system, Zhao et al. grafted the light-responsive azobenzene group on the surface of biodegradable MSNs, and β-cyclodextrin-modified polymer as the cap agent. In vitro experiments verified that the visible light triggered the isomerization of azobenzene, followed by the dissociation of CD-PMPC from MSNs surface and following drug release. The excellent anti-inflammatory effect of MSNs-based platform shown their potential in the treatment of osteoarthritis. 274 Regarding enzyme-responsive drug delivery system, some researchers reported the synthesis of MSNs attached with chitosan gatekeeper via azo bonds. The azo bonds could be cleaved by the colon-specific enzyme, leading to the separation of chitosan gatekeeper and the release of DOX. 334 In all, these functionalized MSNs-based drug delivery systems that specifically respond multiple stimulus signals provide a precisely localized and targeted way for illness treatments.
What is the difference between fumed silica and precipitated silica?
silicon dioxide CAS 7631-86-9
What drives silica raw material prices?
silica flow agent Secondly, it is needed to construct simple but efficient MSNs-based nanoplatforms. The abundant traits of MSNs have led to their vast exploitation as multifunctional nanocarriers, and this may be accompanied by the introduction of two or more elements into MSNs. Although these multifunctional nanoplatforms have proven to be really effective in numerous papers, the complexity of these platforms does not appear to be friendly to the scale-up preparation and clinical translation. On the one hand, it is well known that the laboratory-level synthesis methods of MSN are very different from those used for industrial scale-up production required for clinical screening and use. The reproducibility and batch stability of nanoformulations are always an important component to consider in industrial scale-up production, and in this process, simplifying the production steps is the key to promote the industrial scale-up production. Nonetheless, the complex MSNs-based nanoplatforms call for higher nanoformulation preparation technologies and more stringent storage methods, which often call for more time, effort, and economic investments. On the other hand, the multiple components may introduce more unsafe factors, it appears to be an enormous challenge at this stage to systematically reveal the toxicity mechanisms of these different components when we still do not entirely understand the toxicity mechanisms of MSNs. Hence, it is advocated to slim down the MSNs-based platform as much as possible while meeting the clinical requirements.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.